Gene · 51592
TRIM33: tripartite motif containing 33
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TRIM33: tripartite motif containing 33. Genes, record 51592. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51592
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UPN9 | E3 ubiquitin-protein ligase TRIM33 | 1,127 | 9 | Ensembl, GeneID, HGNC |
Source UniProt
Patents30
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 68057 | Q9UPN9 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7551 | Q9UPN9 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 1129 | Q9UPN9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7559 | Q9UPN9 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 1129 | Q9UPN9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7559 | Q9UPN9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7551 | Q9UPN9 | Espacenet |
| JP 2024161501 A | 2024-11-19 | 66 | Q9UPN9 | Espacenet |
| KR 1020240108531 A | 2024-07-09 | 66 | Q9UPN9 | Espacenet |
| EP 4223770 A2 | 2023-08-09 | 16 | Q9UPN9 | Espacenet |
1 to 10 of 30
See all 30 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants881
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TRIM33 papers | Newest fiscal year |
|---|---|---|---|
| ZIAAR041203 | Muscle Disease Unit | 22 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 20 | 2025 |
| ZIAES101074 | Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease | 17 | 2025 |
| P30AR070254 | Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC) | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| R01AR073208 | Autoantibodies define scleroderma subgroups with distinct relationships to cancer | 9 | 2025 |
| ZIAES101081 | Assessment, Therapy and Prevention Of Autoimmune Disease | 7 | 2025 |
| P30CA072720 | Cancer Center Support Grant | 4 | 2025 |
| T32AR050942 | Training Program in Adult and Pediatric Rheumatology | 4 | 2025 |
| ZIADE000704 | Clinical and Mechanistic Investigations of Salivary Gland Dysfunction | 4 | 2025 |
1 to 10 of 881Source NIH's project files
See all 881 nih grantsPapers2,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Age-dependent myositis-specific autoantibody profiles and CD8+ T-cell signatures in juvenile dermatomyositis. | Immunol Med | 2026 | 42808692 | PubTator, text mining | PubMed |
| Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer. | Signal Transduct Target Ther | 2026 | 42805968 | PubTator, text mining | PubMed |
| The TIF-1γ autoantigen in patients with dermatomyositis and thyroid cancer: from case series to preliminary mechanistic exploration. | Front Immunol | 2026 | 42774280 | PubTator, text mining | PubMed |
| Catching up with calcinosis: analysis of clinical characteristics, myositis-specific autoantibodies, and response to therapy in juvenile dermatomyositis. | Clin Exp Rheumatol | 2026 | 42752384 | PubTator, text mining | PubMed |
Multicenter Clinical Comparison Between Anti-NXP2 and Anti-TIF1-γ Antibody-Positive Myositis, and Analysis of the Clinical Significance of Anti-NXP2 Antibody Titers in Idiopathic Inflammatory Myopathies. | J Dermatol | 2026 | 42750350 | PubTator, text mining | PubMed |
| Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis. | An Bras Dermatol | 2026 | 42696844 | PubTator, text mining | PubMed |
| Clinical characteristics, organ damage and survival in idiopathic inflammatory myopathies: a long-term retrospective cohort study. | Rheumatol Int | 2026 | 42667319 | PubTator, text mining | PubMed |
| A five-factor risk-stratification model for cancer-associated myositis in idiopathic inflammatory myopathies and stage-specific survival analysis: a multicentre Japanese MYKO cohort study. | Front Immunol | 2026 | 42643601 | PubTator, text mining | PubMed |
| Proteomic Signatures and an Injury-Stress Endotype in Myositis-Associated Interstitial Lung Disease. | medRxiv | 2026 | 42620435 | PubTator, text mining | PubMed |
| TIF1γ holds the line against regulatory T cell plasticity. | Nat Immunol | 2026 | 42601472 | PubTator, text mining | PubMed |
1 to 10 of 2,289
See all 2,289 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/51592
GET https://conductscience.org/api/genes/v1/51592/patents?page=2